Plasma and Brain-Derived Extracellular Vesicle Biomarkers Following a Randomized Controlled Trial of Choline for Neurodevelopment in Fetal Alcohol Spectrum Disorder: A Pilot Analysis
Nutrients · 16.09.2026 · 18 (18) · 3022
DOI: 10.3390/nu18183022 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 16.09.2026. Verfasst von Phu V Tran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Choline, Fetal Alcohol Spectrum Disorders, Extracellular Vesicles, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAAA NIH HHS, Masonic Institute for the Developing Brain.
Abstract (Originalsprache)
Background
Postnatal choline supplementation improves memory, non-verbal IQ, executive function, and white-matter microstructure in children with fetal alcohol spectrum disorder (FASD) across randomized controlled trials; however, peripheral and brain biomarkers of these effects are uncharacterized.
Methods
We measured eight immune and neurotrophic biomarkers (TNFα, transferrin receptor 1 [TfR1], BDNF, ferritin, MCP-1, RANTES, CRP, and Eotaxin) in plasma and brain-derived extracellular vesicles (BDEVs) from 24 children with FASD randomized to choline (n = 13; 7 male, 6 female) or placebo (n = 11; 7 male, 4 female), before and approximately nine months after treatment (23 with paired pre/post samples). Values were log10-transformed to correct for non-normal distribution. We modeled Group × Time effects with linear mixed models, adjusted for age, sex, and sample storage duration, cross-checked with cluster-robust ordinary least squares, and tested plasma-to-BDEV concordance for each analyte with linear regression adjusted for age and sex. Multiplicity was corrected by Benjamini–Hochberg FDR.
Results
Plasma MCP-1 showed a nominally significant Group × Time interaction (p = 0.035, q = 0.28), rising over time in the placebo but not the choline group. Ferritin and CRP showed similar patterns that did not reach significance (interaction p = 0.099 and p = 0.118; q = 0.31 for both). RANTES and BDNF rose significantly in BDEVs over time, without evidence of a differential change by treatment group, and survived FDR correction (both q ≤ 0.02); ferritin also rose significantly (p = 0.021) but its Time effect did not survive FDR correction (q = 0.06). BDEV TfR1 was nominally lower in the choline group than placebo at both timepoints (p = 0.023; q = 0.13). Plasma levels were associated with BDEV levels for five markers (ferritin, TfR1, TNFα, Eotaxin, RANTES; all p < 0.05), independent of age, sex, time, and group; all five associations survived FDR correction (q ≤ 0.01). The plasma-BDEV association for MCP-1 became non-significant when adjusted for time and group (p = 0.134, q = 0.13). CRP and BDNF showed a between-person, but not within-person, plasma-BDEV association.
Conclusions
In this small, exploratory sample of children with FASD, a condition characterized by brain iron deficiency and inflammation, choline was associated with an attenuated rise in pro-inflammatory plasma MCP-1 relative to placebo, generating a new hypothesized candidate biomarker for further study. Most BDEV markers changed over time (Pre-to-Post), not with treatment. Plasma and BDEV BDNF were not significantly associated overall, although a between-person association was present without a corresponding within-person signal, suggesting that inferring central nervous system function from plasma BDNF should proceed with caution. These hypothesis-generating findings support further, larger-scale investigation of BDEV content analysis as a candidate complement to this trial program’s cognitive and neuroimaging outcomes. Replication and expansion of the BDEV panel of analytes in a larger sample are needed.
Trial registration
ClinicalTrials.Gov [NCT02735473]; registered 2 April 2016.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
- Masonic Institute for the Developing Brain, University of Minnesota, Minneapolis, MN 55455, USA.
- Nutrition Research Institute, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA.
- Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Phu V Tran, Zia L Maxim, Michael K Georgieff, Jeffrey R Wozniak
Förderung
- NIH HHS
- NIAAA NIH HHS
- Masonic Institute for the Developing Brain
- National Institutes of Health
Zitieren
APA
Tran, P. V., Maxim, Z. L., Eckerle, J. K., Zeisel, S. H., Georgieff, M. K., & Wozniak, J. R. (2026). Plasma and Brain-Derived Extracellular Vesicle Biomarkers Following a Randomized Controlled Trial of Choline for Neurodevelopment in Fetal Alcohol Spectrum Disorder: A Pilot Analysis. Nutrients, 18(18), 3022. https://doi.org/10.3390/nu18183022
Vancouver
Tran PV, Maxim ZL, Eckerle JK, Zeisel SH, Georgieff MK, Wozniak JR. Plasma and Brain-Derived Extracellular Vesicle Biomarkers Following a Randomized Controlled Trial of Choline for Neurodevelopment in Fetal Alcohol Spectrum Disorder: A Pilot Analysis. Nutrients. 2026;18(18):3022. doi:10.3390/nu18183022
BibTeX
@article{Tran2026,
author = {Tran, Phu V and Maxim, Zia L and Eckerle, Judith K and Zeisel, Steven H and Georgieff, Michael K and Wozniak, Jeffrey R},
title = {Plasma and Brain-Derived Extracellular Vesicle Biomarkers Following a Randomized Controlled Trial of Choline for Neurodevelopment in Fetal Alcohol Spectrum Disorder: A Pilot Analysis},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {18},
pages = {3022},
doi = {10.3390/nu18183022}
}
EUVIMED